口服药物对增生性糖尿病视网膜病变术后康复效果的影响

Rehabilitation effect of oral drug on the patients with proliferative diabetic retinopathy after operation

摘要:

目的：观察口服羟苯磺酸钙片联合依帕司他片，对增生性糖尿病视网膜病变(proliferative diabetic retinopathy，PDR)玻璃体切割手术后患者康复效果的影响。

方法：在PDR玻璃体切割手术后患者知情同意的情况下进行随机分组，分为术后药物干预组及对照组，术后2d； 3，6，9，12mo随访视力及眼底情况，并进行比较。

结果：药物干预组视力恢复及保持较好，且黄斑水肿消退情况明显优于对照组。

结论：PDR患者玻璃体切割手术后，积极口服保护视网膜的药物进行干预有利于视力的提高和眼底的康复。

Abstract:

AIM:To observe the rehabilitation effect of oral Calcium Dobesilate Tablets and Epalrestat Tablets on the proliferative diabetic retinopathy(PDR)patients after vitrectomy.

METHODS: After vitrectomy patients informed consent, they were randomly divided into intervention group and control group, and their vision and fundus were followed up and compared at 2d; 3, 6, 9, 12mo after operation.

RESULTS: The recovery and sustainment of visual acuity, and subsiding of macular edema of patients in drug intervention group were significantly better than that in control group.

CONCLUSION: PDR patients after vitrectomy actively orally take medicine to protect retina, which can improve vision and fundus rehabilitation.